uniQure plans BLA submission for Huntington's therapy in Q3 2026

Go back to uniQure plans BLA submission for Huntington's therapy in Q3 2026
UNIQURE (NASDAQ: QURE) Delayed: 44.50 -0.36 (0.8%)
Previous Close $44.86    52 Week High $22.79 
Open $44.91    52 Week Low $6.63 
Day High $45.16    P/E N/A 
Day Low $43.90    EPS $0.00 
Volume 991,476